VerAvanti
Bothell
About VerAvanti
VerAvanti is a deep tech enterprise dedicated to bringing Scanning Fiber Endoscopy (“SFE”) to the field of medicine. SFE technology will provide 1080p video images using a single use sterile 1 mm. imaging catheter. We are finalizing the manufacturing process to mass produce the single use sterile SFE and expect to introduce a family of groundbreaking medical devices early-2026. SFE technology is a quantum leap forward in medical imaging and will provide currently unavailable visualization capabilities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $38.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2025)
- Website: veravanti.com
- Phone: (425) 201-6070
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/veravanti-45033 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.